These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32507930)

  • 1. Cardiac manifestations in a western moyamoya disease population: a single-center descriptive study and review.
    Larson AS; Savastano L; Klaas J; Lanzino G
    Neurosurg Rev; 2021 Jun; 44(3):1429-1436. PubMed ID: 32507930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of autoimmune disease in moyamoya disease patients in Western Chinese population.
    Chen JB; Liu Y; Zhou LX; Sun H; He M; You C
    J Neurol Sci; 2015 Apr; 351(1-2):184-186. PubMed ID: 25743224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of pro-thrombotic conditions in adult patients with moyamoya disease and moyamoya syndrome: a single center study.
    Larson A; Rinaldo L; Lanzino G; Klaas JP
    Acta Neurochir (Wien); 2020 Aug; 162(8):1853-1859. PubMed ID: 32462312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of moyamoya disease in Hawaii.
    Graham JF; Matoba A
    Clin Neurol Neurosurg; 1997 Oct; 99 Suppl 2():S31-5. PubMed ID: 9409401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and clinical implications of renal artery stenosis in pediatric moyamoya disease.
    Baek JW; Jo KI; Park JJ; Jeon P; Kim KH
    Eur J Paediatr Neurol; 2016 Jan; 20(1):20-4. PubMed ID: 26652853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features of moyamoya disease with Graves' disease: a retrospective study of 394,422 patients with thyroid disease.
    Hiruma M; Watanabe N; Mitsumatsu T; Suzuki N; Fukushita M; Matsumoto M; Yoshihara A; Yoshimura Noh J; Sugino K; Ito K
    Endocr J; 2023 Feb; 70(2):141-148. PubMed ID: 36198616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moyamoya Disease and Syndrome: A National Inpatient Study of Ischemic Stroke Predictors.
    Unda SR; Antoniazzi AM; Miller R; Klyde D; Javed K; Fluss R; Holland R; De la Garza Ramos R; Haranhalli N; Altschul DJ
    J Stroke Cerebrovasc Dis; 2021 Sep; 30(9):105965. PubMed ID: 34247053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Moyamoya Disease in China: Single-Center, Population-Based Study.
    Bao XY; Wang QN; Zhang Y; Zhang Q; Li DS; Yang WZ; Zhang ZS; Zong R; Han C; Duan L
    World Neurosurg; 2019 Feb; 122():e917-e923. PubMed ID: 30404059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease.
    Chen JB; Liu Y; Zhou LX; Sun H; He M; You C
    J Neurosurg; 2016 May; 124(5):1215-20. PubMed ID: 26406790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nationwide survey on quasi-moyamoya disease in Japan.
    Hayashi K; Horie N; Izumo T; Nagata I
    Acta Neurochir (Wien); 2014 May; 156(5):935-40. PubMed ID: 24499994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracranial Aneurysms in Adult Moyamoya Disease.
    Kim JH; Kwon TH; Kim JH; Chong K; Yoon W
    World Neurosurg; 2018 Jan; 109():e175-e182. PubMed ID: 28962951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ecological comparison study on the causal association between leptospirosis and moyamoya disease in Hubei, China, 2017-2019.
    Ma Z; Wang X; Li M; Zhou D; Chen J
    Clin Neurol Neurosurg; 2021 Nov; 210():107007. PubMed ID: 34741974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Study on Clinical Features of Childhood Moyamoya Disease.
    Wang Y; Kong H; Wang Y; Jin P; Ding J; Li H; Wang H; Zhuo Z
    Pediatr Neurol; 2023 Jan; 138():17-24. PubMed ID: 36335837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of familial juvenile cases of moyamoya disease: analysis of patients treated in a single institute over a 28-year period.
    Mukawa M; Nariai T; Matsushima Y; Ohno K
    J Neurosurg Pediatr; 2013 Aug; 12(2):175-80. PubMed ID: 23725354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bypass surgery versus medical treatment for symptomatic moyamoya disease in adults.
    Jang DK; Lee KS; Rha HK; Huh PW; Yang JH; Park IS; Ahn JG; Sung JH; Han YM
    J Neurosurg; 2017 Sep; 127(3):492-502. PubMed ID: 27834597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course of asymptomatic adult moyamoya disease.
    Jo KI; Yeon JY; Hong SC; Kim JS
    Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of and Risk Factors for Cerebral Microbleeds in Moyamoya Disease and Syndrome in the American Population.
    Khan NI; Saherwala AA; Chen M; Salehian S; Salahuddin H; Welch BG; Pinho MC; Shang T
    Cerebrovasc Dis Extra; 2019; 9(3):139-147. PubMed ID: 31830749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.
    Bao XY; Duan L; Li DS; Yang WZ; Sun WJ; Zhang ZS; Zong R; Han C
    Cerebrovasc Dis; 2012; 34(4):305-13. PubMed ID: 23146868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.
    Liu XJ; Zhang D; Wang S; Zhao YL; Teo M; Wang R; Cao Y; Ye X; Kang S; Zhao JZ
    J Neurosurg; 2015 Feb; 122(2):392-9. PubMed ID: 25423267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cephalic/cardiac neural crest cell and moyamoya disease.
    Ota T; Komiyama M
    Neuroradiol J; 2021 Dec; 34(6):529-533. PubMed ID: 34078151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.